Open access · CC-BY
via OpenAlex
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan, Andrew Feyh, Haresh Visweshwar, Joseph I. Shapiro, Komal Sodhi
International Journal of Medical Sciences · 2015 · ▲ 441 citations
Abstract
INTRODUCTION: Metabolic syndrome represents a cluster of related metabolic abnormalities, including central obesity, hypertension, dyslipidemia, hyperglycemia, and insulin resistance, with central obesity and insulin resistance in particular recognized as causative factors. These metabolic derangements present significant risk factors for cardiovascular disease, which is commonly recognized as the primary clinical outcome, although other outcomes are possible. Metabolic syndrome is a progressive condition that encompasses a wide array of disorders with specific metabolic abnormalities presenting at different times. These abnormalities can be detected and monitored via serum biomarkers. This review will compile a list of promising biomarkers that are associated with metabolic syndrome and this panel can aid in early detection and management of metabolic syndrome in high risk populations, such as in West Virginia. METHODS: A literature review was conducted using PubMed, Science Direct, and Google Scholar to search for markers related to metabolic syndrome. Biomarkers searched included adipokines (leptin, adiponectin), neuropeptides (ghrelin), pro-inflammatory cytokines (IL-6, TNF-α), anti-inflammatory cytokines (IL-10), markers of antioxidant status (OxLDL, PON-1, uric acid), and prothrombic factors (PAI-1). RESULTS: According to the literature, the concentrations of pro-inflammatory cytokines (IL-6, TNF-α), markers of pro-oxidant status (OxLDL, uric acid), and prothrombic factors (PAI-1) were elevated in metabolic syndrome. Additionally, leptin concentrations were found to be elevated in metabolic syndrome as well, likely due to leptin resistance. In contrast, concentrations of anti-inflammatory cytokines (IL-10), ghrelin, adiponectin, and antioxidant factors (PON-1) were decreased in metabolic syndrome, and these decreases also correlated with specific disorders within the cluster. CONCLUSION: Based on the evidence presented within the literature, the aforementioned biomarkers correlate significantly with metabolic syndrome and could provide a minimally-invasive means for early detection and specific treatment of these disorders. Further research is encouraged to determine the efficacy of applying these biomarkers to diagnosis and treatment in a clinical setting.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7150/ijms.13800
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J.I., & Sodhi, K. (2015). Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. <em>International Journal of Medical Sciences</em>. https://doi.org/10.7150/ijms.13800
Vancouver
Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. International Journal of Medical Sciences. 2015. doi:10.7150/ijms.13800.
BibTeX
@article{krithika2015System,
title = {Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population},
author = {Krithika Srikanthan and Andrew Feyh and Haresh Visweshwar and Joseph I. Shapiro and Komal Sodhi},
journal = {International Journal of Medical Sciences},
year = {2015},
doi = {10.7150/ijms.13800},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Medical Sciences 2017
Open access · CC-BY
Inflammatory Biomarkers of Cardiometabolic Risk in Obese Egyptian Type 2 Diabetics
African Journal of Biomedical Research 2026
Open access · CC-BY
Inflammaging in Cardiovascular Disease: Emerging Mechanisms and Therapeutic Perspectives
Journal of Diabetes Investigation 2013
Open access · OA
Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness
Journal of Pharmaceutical Negative Results 2022
Open access · OA
Inflammatory Biomarkers In Early Detection Of Acute Coronary Syndrome
World Journal of Cardiology 2015
Open access · CC-BY
Therapeutic modification of arterial stiffness: An update and comprehensive review
Biomedicines 2023
Open access · CC-BY